Abstract
To compare the clinical outcomes of dual triggering with gonadotropin releasing hormone (GnRH) agonist and human chorionic gonadotropin (hCG) in POSEIDON groups 3 and 4 low prognosis women with hCG only triggering, in antagonist cycles.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
